Add more content here...


Loco-regional modulated electro-hyperthermia (mEHT) device

The EHY-2030 device is intended for the adjuvant treatment of glioblastoma in a combination regimen with chemotherapy and/or radiation therapy. The newly designed device includes the Smart Electrode system and the integrated Patient Management System (PMS) and a user-friendly touch screen display with full system control. The new RF generator with impulse mode increased peak power has been developed with a new intelligently controlled step motor tuning system for rapid impedance matching to achieve shorter tuning-time.

The EHY-2030 device is a CE-marked medical device, and is intended for professional use.

Technical specifications

Mains voltage: 100 - 230 VAC 50/60 Hz

RF power output: max. 350 W(eff) / 800 W(pp)

Nominal load: 50 Ohm

Output carrier frequency: 13,56 Mhz

Output modulating frequency: Pink noise

Required space: min. 12 m2

Recommended space: 14 m2

Weight: 200 kg

Dimensions (HxLxW): 1320 x 2500 x 1150 mm

Operating conditions:

Temperature: +15°C - +30°C

Relative air humidity: 20% - 60% (non-condensing)

Air pressure: 800 - 1060 hPa